NEW YORK — The company that creates a rapid HIV testing kit saw its stock jump Wednesday morning after a home version of the 30-minute oral test hit store shelves.
Earlier this year, the FDA approved for home use the OraSure rapid test that does not require samples be sent to a lab, and allows for nearly instant, private home results. CNBC reports that the stock was up nearly 50 cents after tests went on sale.
The test screens for the presence in saliva of the ineffective antibodies the body produces when infected with HIV. Advocates hope that the confidential test may encourage those that normally would not get tested to learn their status, and seek out proper care if needed.